CHA2DS2-VASc score is useful in predicting poor 12-month outcomes following myocardial infarction in diabetic patients without atrial fibrillation

• DOI: 10.1007/s00592-016-0877-6
• Publication Date: 2016-06-23T17:14:59Z
• Authors: Bartosz Hudzik; Janusz Szkodziński; Michal Hawranek; Andrzej Lekston; Lech Poloński; Mariusz Gąsior
• Keywords: CHA2DS2–VASc score; Interquartile range; Stroke; TIMI

TIMI risk score and GRACE model are widely available accepted scores for assessment in STEMI patients include predictors of poor outcomes. CHA2DS2-VASc is a validated predicting embolic/stroke with non-valvular atrial fibrillation. Its components contribute to the worse prognosis following myocardial infarction. The advantage comparison other that it provides comprehensive, fast, simple method physicians evaluation requires no calculators or computers. Therefore, we have set out examine prognostic significance diabetic without AF. A total 472 diabetes mellitus undergoing primary PCI were enrolled. Based on estimated score, study population was divided into three groups: group 1 (N = 111) moderate 2 3; 257) high 4 5; 3 104) very 6 higher. In STEMI, median (interquartile range 3–5). In-hospital mortality rate similar across groups. not factor in-hospital mortality. ROC analysis revealed good diagnostic value long-term (AUC 0.62 95 % CI 0.57–0.66 P 0.0003) stroke 0.75 0.71–0.79 0.0003), but an independent predictor 12-month stroke. One-point increment associated increase death by 24 101 %. previous AF, (4 points) predicted However, failed predict MI. had discrimination performance as better than score. Thus, can serve additive tool identifying high-risk require aggressive management.